Dr. Kawaljit Kaur

Chief Scientific Officer and Director

Dr. Kawaljit Kaur leads NK Immuno T’s ALS research strategy, biomarker development and preclinical planning. Her expertise spans innate immunity, cancer immunology and neurodegenerative disease research.

She earned her M.S. and Ph.D. at UCLA, where she trained under Dr. Anahid Jewett, and served as a UCLA faculty scientist from 2017 to 2024. She also serves as Acting Chief Executive Officer of ImmuneLink LLC and Scientific Advisor to NKore Biotherapeutics.